Topics

Latest

AI

Amazon

Article image

Image Credits:Sword Health / Company

Apps

Biotech & Health

mood

Sword Health

Image Credits:Sword Health / Company

Cloud Computing

Commerce

Crypto

endeavor

EVs

Fintech

Fundraising

widget

punt

Google

Government & Policy

Hardware

Instagram

Layoffs

Media & Entertainment

Meta

Microsoft

Privacy

Robotics

Security

societal

blank space

Startups

TikTok

Transportation

speculation

More from TechCrunch

event

Startup Battlefield

StrictlyVC

Podcasts

picture

Partner Content

TechCrunch Brand Studio

Crunchboard

Contact Us

Sword Health , an AI - power virtual forcible therapy startup , has raised $ 30 million and have employees sell $ 100 million Charles Frederick Worth of equity to new and exist investors , including Khosla Ventures . The bout convey the nine - twelvemonth - former company ’s rating to $ 3 billion , a 50 % increment from the   $ 2 billion economic value it   collect in its Series D in November 2021 .

“ It ’s a very intense environment : foresighted hours and high expectations . We wanted to reinforce our squad , specially our other employees , ” he said .

Sword did n’t need the inflow of   capital because it ’s forecasted to be profitable by the destruction of the class , Bento said . However , he liked the signal an updated valuation would ship during the tough fundraising conditions of 2024 .

“ No one really believes in the valuation of 2021 given how irrational the market was , ” Bento said . While most employee have a go at it that the troupe is doing well , Sword ’s clients , who admit employer and health plan of Fortune 500 company , had no clear-cut way of approximate the company ’s progress .   “ We wanted to showcase our growth , and rating is one index number of that . ”

The company wo n’t use the $ 30 million for operations . “ It ’s going to be in the bank , bring forth dainty interest , ” Bento said .

The latest principal round brings Sword ’s entire funding to $ 340 million . In addition to Khosla Ventures , the company ’s investors include General Catalyst , BOND , Founders Fund , and others .

Join us at TechCrunch Sessions: AI

Exhibit at TechCrunch Sessions: AI

turn out that Sword is doing so well is likely crucial to the company because it contend directly with another virtual therapy platform , Hinge Health , which was last assess at$6.2 billion in October 2021 . In April , Hinge set off 10 % of its workforce as a step in its program to reach profitableness in preparation for a potential IPO , TechCrunch describe .

Bento also has a goal of an IPO for Sword . If the society acquire as expected and the macroeconomic environment is golden , it could potentially list in 2025 , but the fellowship is not attached to a specific timeline , Bento said .

In the lag , the company is beefing up its AI . It is introducing a human - like voice for its genAI , named Phoenix , to its musculoskeletal therapy and women ’s pelvic health care therapy . Phoenix   powers all patient fundamental interaction and Sword ’s virtual therapist . “ It ’s the last firearm of the puzzle that makes Phoenix much more engaging , ” Bento enounce .